title: How I do it: managing bone health in patients with prostate cancer.
abstract: Urologists have two scenarios where they have to address bone loss or increased risk of fractures in men with prostate cancer. In the first setting, a patient who has been started on androgen deprivation therapy may develop cancer-treatment-induced bone loss. In the second setting, a patient's prostate cancer may have metastasized to the bone. This article describes six steps to manage bone health in patients diagnosed with prostate cancer in a community practice.
authors.affiliation: Humber River Hospital, Toronto, Ontario, Canada.
authors.forename: Jack
authors.initials: J
authors.lastname: Barkin
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D015519:Bone Density / Q000502:physiology; D001859:Bone Neoplasms / Q000453:epidemiology / Q000517:prevention & control* / Q000556:secondary*; D001862:Bone Resorption / Q000453:epidemiology / Q000517:prevention & control*; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000503:physiopathology; D002118:Calcium / Q000097:blood; D019587:Dietary Supplements; D019468:Disease Management; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D014807:Vitamin D / Q000097:blood
chemical_list: D000726:Androgen Antagonists; D014807:Vitamin D; D002118:Calcium